Form 4 for ATRA Atara Biotherapeutics, Inc.
Accepted 2023-08-18 00:00:00 ET · period of report 2023-08-16 · accession 0001140361-23-040560 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2023-08-18 | 2023-08-16 | ATRA | Joshi Manher | EVP, Chief Medical Off | S - Sale | $1.65 | -6,975 | 183.6K | -4% | -$11.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-08-16 | S | D | 3,202 | $1.65 | 187,344 | D | — | — | (F2) The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on August 16, 2023 and August 17, 2023 on behalf of a group of employees of the Issuer to satisfy the payment of withholding tax liability of such employee. |
| 2 | Common | Common Stock | 2023-08-16 | S | D | 3,773 | $1.65 | 183,571 | D | — | — | (F2) The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on August 16, 2023 and August 17, 2023 on behalf of a group of employees of the Issuer to satisfy the payment of withholding tax liability of such employee. |